Literature DB >> 17185111

Contribution of systolic and diastolic abnormalities to heart failure with a normal and a reduced ejection fraction.

Hidekatsu Fukuta1, William C Little.   

Abstract

Heart failure (HF) has traditionally been divided into HF with a reduced ejection fraction (EF; systolic HF) and HF with a normal EF (diastolic HF). Both groups have reductions in exercise tolerance, neurohumoral activation, and abnormal left ventricular (LV) filling dynamics and impaired relaxation. Although the normal EF indicates that pump performance is adequately compensated, some of the patients with HF and a normal EF have reduced longitudinal systolic velocity indicating cardiac muscular contractile dysfunction. Regardless of EF, the severity of HF and its prognosis and degree of exercise intolerance are closely related to the degree of diastolic filling abnormalities. Patients with HF and a reduced EF have ventricular dilatation and elongated myocytes, whereas patients with HF and a normal EF do not. Thus, patients with HF have diastolic abnormalities regardless of EF and many patients with HF and a normal EF have contractile abnormalities despite preserved systolic pump performance. Heart failure with a normal EF and a reduced EF differs in the systolic LV pump performance and the type of remodeling. The mechanism of the differing remodeling responses is not known, but aging, sex differences, and diabetes may contribute.

Entities:  

Mesh:

Year:  2007        PMID: 17185111     DOI: 10.1016/j.pcad.2006.08.009

Source DB:  PubMed          Journal:  Prog Cardiovasc Dis        ISSN: 0033-0620            Impact factor:   8.194


  17 in total

1.  Decreased cardiac functional reserve in heart failure with preserved systolic function.

Authors:  Holly S Norman; James Oujiri; Shane J Larue; Carrie B Chapman; Kenneth B Margulies; Nancy K Sweitzer
Journal:  J Card Fail       Date:  2010-12-24       Impact factor: 5.712

Review 2.  Heart failure with preserved ejection fraction: pathophysiology, diagnosis, and treatment.

Authors:  Barry A Borlaug; Walter J Paulus
Journal:  Eur Heart J       Date:  2010-12-07       Impact factor: 29.983

3.  Diastolic and systolic heart failure are distinct phenotypes within the heart failure spectrum.

Authors:  Barry A Borlaug; Margaret M Redfield
Journal:  Circulation       Date:  2011-05-10       Impact factor: 29.690

Review 4.  Exercise and heart failure in the elderly.

Authors:  Tissa Kappagoda; Ezra A Amsterdam
Journal:  Heart Fail Rev       Date:  2012-09       Impact factor: 4.214

5.  Locomotor Muscle Microvascular Dysfunction in Heart Failure With Preserved Ejection Fraction.

Authors:  Michael A Francisco; Joshua F Lee; Zachary Barrett-O'Keefe; H Jonathan Groot; Stephen M Ratchford; Kanokwan Bunsawat; Jeremy K Alpenglow; John J Ryan; Jose N Nativi; Russell S Richardson; D Walter Wray
Journal:  Hypertension       Date:  2021-11-01       Impact factor: 10.190

6.  Cardiac-restricted overexpression of extracellular matrix metalloproteinase inducer causes myocardial remodeling and dysfunction in aging mice.

Authors:  Juozas A Zavadzkas; Rebecca A Plyler; Shenikqua Bouges; Christine N Koval; William T Rivers; Christy U Beck; Eileen I Chang; Robert E Stroud; Rupak Mukherjee; Francis G Spinale
Journal:  Am J Physiol Heart Circ Physiol       Date:  2008-08-08       Impact factor: 4.733

Review 7.  The cardiac cycle and the physiologic basis of left ventricular contraction, ejection, relaxation, and filling.

Authors:  Hidekatsu Fukuta; William C Little
Journal:  Heart Fail Clin       Date:  2008-01       Impact factor: 3.179

8.  Coronary capillary blood flow in a rat model of congestive heart failure.

Authors:  Heather J Kagan; Varujan D Belekdanian; Jiqiu Chen; Peter Backeris; Nadjib Hammoudi; Irene C Turnbull; Kevin D Costa; Roger J Hajjar
Journal:  J Appl Physiol (1985)       Date:  2017-10-19

Review 9.  The clinical quandary of left and right ventricular diastolic dysfunction and diastolic heart failure.

Authors:  E R Schwarz; R Dashti
Journal:  Cardiovasc J Afr       Date:  2010 Jul-Aug       Impact factor: 1.167

Review 10.  The cGMP signaling pathway as a therapeutic target in heart failure with preserved ejection fraction.

Authors:  Stephen J Greene; Mihai Gheorghiade; Barry A Borlaug; Burkert Pieske; Muthiah Vaduganathan; John C Burnett; Lothar Roessig; Johannes-Peter Stasch; Scott D Solomon; Walter J Paulus; Javed Butler
Journal:  J Am Heart Assoc       Date:  2013-12-11       Impact factor: 5.501

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.